Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market for Parkinson’s Disease (Product Type: Single-Channel Deep Brain Stimulator and Dual-Channel Deep Brain Stimulator; and End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Deep Brain Stimulation Devices Market Outlook 2028

  • The global market was valued at US$ 0.85 Bn in 2020
  • It is estimated to expand at a CAGR of 5.1% from 2021 to 2028
  • The global deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by the end of 2028

Analysts’ Viewpoint on Deep Brain Stimulation Devices Business for Parkinson’s Disease Scenario

Telehealth and eHealth apps are gaining popularity during the ongoing coronavirus pandemic to routinely monitor PD patients. Favorable reimbursement policies across healthcare facilities worldwide are contributing to the expansion of the deep brain stimulation devices market for Parkinson’s disease. However, there is a need for technological advancements in implantable pulse generators of DBS systems. Hence, companies in the global market for Parkinson’s disease should increase R&D for maximizing battery longevity, combined with patient-related elements such as reliability of IPG recharging or consistency of nightly device shutoff. Device-specific features such as parameter delivery, choice of lead configuration, implantation location, and careful selection of electrode materials to minimize impedance mismatch are crucial for med-tech companies to gain a competitive edge in the global market.

Commercialization of Portable, Affordable, and Effective DBS Devices

Companies operating in the deep brain stimulation devices market for Parkinson's disease are increasing efforts to commercialize devices in the global market. Products of other companies active in the market for DBS (deep brain stimulation) are not yet commercially available, as these are still under clinical trial. Companies are keen on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.

Request a sample to get extensive insights into the Deep Brain Stimulation Devices Market

Telehealth Helps Address Challenges of PD Patients amid Coronavirus Pandemic

The containment measures taken by various government authorities during the ongoing coronavirus pandemic have caused the interruption of neurological activities in outpatient clinics. Vulnerable patients suffering from Parkinson's disease (PD) and dystonic patients with deep brain stimulation may have an increased risk of chronic stress related to social restriction measures and show a potential worsening of motor & psychiatric symptoms. In such cases, telehealth and eHealth mobile apps are playing a key role to address the symptoms of PD patients. Moreover, med-tech companies are increasing efforts to maintain a robust supply of DBS devices to prevent interruptions in the medical treatment of patients.

To understand how our report can bring a difference to your business strategy, Ask for a brochure

DBS Surgical Therapy V/S Drug Therapy: Which is Better?

According to analysts at Transparency Market Research (TMR), the growing popularity of minimally invasive procedures is estimated to drive the demand for deep brain stimulation devices for Parkinson's disease. Deep brain stimulation surgical therapy is currently gaining traction and has risen to a popular therapy of choice when Parkinson's disease in the patient is at its advanced stage.

Since drug therapy is associated with certain adverse events, doctors, and patients are increasingly opting for deep brain stimulation surgical therapies. In addition, the efficacy of drug therapy cannot be determined in terms of certainty. This is another factor, which is driving doctors and patients to choose deep brain stimulation surgical therapy over drug therapy.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Medical Robotics Market

Popularity of DBS Devices for Surgical Procedures in America Benefits Med-tech Companies

The global deep brain stimulation devices market for Parkinson’s disease is positioned to register a modest CAGR throughout the forecast period. North America is predicted to dictate the global market during the forecast period, accounting for more than 30% to 40% share by 2028. The market in the region is anticipated to reach significant value growth by 2028.

North America's largest market share can be attributed to an increase in the number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson’s disease and a surge in the geriatric population. Additionally, favorable government reimbursement policies and the risk of side effects related to medication treatments are expected to boost the growth of the deep brain stimulation devices market for Parkinson’s disease in the region.

Increase in Number of Medical Practitioners Adopting Deep Brain Stimulation Devices

The burgeoning growth of the geriatric population and the rise in demand for minimally invasive surgical techniques are triggering the growth of the deep brain stimulation devices market for Parkinson’s disease. Moreover, the change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the expansion of the global market in the upcoming decade. This is due to considerable side effects and loss of effectiveness of drugs & other therapeutics. This is anticipated to drive the market for DBS devices over the next few years.

Risk of Infection with IPG Affects Acceptance for DBS Devices

The global market for DBS devices is predicted to register favorable Y-o-Y growth throughout the assessment period. However, there are a few factors, which are anticipated to go against the growth of the market. One of the key factors hampering the growth of this market is the associated risks involved with deep brain stimulation procedures.

For instance, an implantable pulse generator (IPG) is the core power supply and programmable element in DBS systems. However, the risk of infections due to IPG is expected to limit the use of deep brain stimulation devices for Parkinson's disease. Hence, healthcare stakeholders should increase awareness about antibiotic impregnation and co-administration & other surgical considerations during IPG implantation such as the use of tack-up sutures & smaller profile devices.

Deep Brain Stimulation Devices Industry: Overview

  • Parkinson’s disease is one of the most common chronic and progressive neurological disorders, which is characterized by postural instability, bradykinesia, akinesia, and tremors due to loss of dopamine-producing neurons in substantia nigra of the mid-brain

Increase in Government Initiatives: Key Driver

  • An increase in the number of neurological disorders such as ischemic stroke, Alzheimer’s disease, tremors, trauma, and Parkinson’s disease (PD) are primary factors responsible for the growth of the global deep brain stimulation devices market
  • Additionally, the surge in the geriatric population and rise in demand for minimally invasive surgical techniques boost the growth of the global market. Moreover, the change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the growth of the global market for deep brain stimulation devices in the near future. This can be attributed to a considerable number of side effects and loss of effectiveness of drugs and other therapies.

North America to Dominate Deep Brain Stimulation Devices Market for Parkinson’s Disease

  • Based on product type, the global market has been segmented into single-channel deep brain stimulators and dual-channel deep brain stimulators
  • In terms of end-user, the global market has been classified into hospitals, ambulatory surgical centers, neurological clinics, and others
  • In terms of region, the global deep brain stimulation devices industry has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global market during the forecast period, accounting for a 38.60% share by 2028. The market in the region is anticipated to reach US$ 0.48 Bn by 2028.
  • North America's largest market share can be attributed to increasing in the number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson’s disease and the surge in the geriatric population. Additionally, favorable government reimbursement policies and the risk of side effects related to medication treatments are expected to boost the growth of the market in North America.
  • The small market share of Asia Pacific, Latin America, and Middle East & Africa can be ascribed to a lack of awareness, lack of favorable government support & other insurance policies, and the high cost of these devices

Major Players

  • Major players operating in the global deep brain stimulation devices market are Medtronic, Inc., St. Jude Medical, Inc., and Boston Scientific Corporation. These companies have commercialized several significant DBS devices in the global market such as Libra, Activa, and Vercise. Other companies that are prominently active in the market are Aleva Neurotherapeutics SA, Adaptive Neuromodulation GmbH (ANM), NeuroSigma, Inc., and NeuroPace, Inc. DBS products of these players are not yet commercially available in the market, as these are still under clinical trials.
  • Companies focus on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.
  • Each of these players has been profiled in the deep brain stimulation devices business report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Deep Brain Stimulation Devices Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 0.85 Bn

Market Forecast Value in 2028

US$ 1.2 Bn

Growth Rate (CAGR)

5.1%

Forecast Period

2017–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Product Type
    • Single-Channel Deep Brain Stimulator
    • Dual-Channel Deep Brain Stimulator
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Neurological Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Deep Brain Stimulation Devices Market for Parkinson’s Disease – Segmentation

TMR’s study on the global market for deep brain stimulation devices includes information divided into three segments: product type, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global market are discussed in detail.

Product Type

  • Single-channel Deep Brain Stimulator
  • Dual-channel Deep Brain Stimulator

End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Clinics
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of deep brain stimulation devices market?

Global market is expected to surpass the value of US$ 1.2 Bn by the end of 2028

What is the anticipated CAGR of the deep brain stimulation devices industry in the forecast period?

The market for deep brain stimulation devices is estimated to expand at a CAGR of 5.1% from 2021 to 2028

What are the key driving factors for the growth of the deep brain stimulation devices market?

The deep brain stimulation devices market is driven by an increase in the geriatric population and a rise in demand for minimally invasive surgical techniques

Which region is expected to project the highest market share in the global deep brain stimulation devices?

North America is projected to dominate the global market for deep brain stimulation devices during the forecast period

Who are the key players in the global deep brain stimulation devices business?

Key players operating in the global market include Medtronic, Inc., St. Jude Medical, Inc., and Boston Scientific Corporation

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Disease Prevalence & Incidence Rate globally with key countries

        5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Product Type

        6.1. Key Findings

        6.2. Market Value Forecast, by Product Type

            6.2.1. Single-Channel Deep Brain Stimulator

            6.2.2. Dual-Channel Deep Brain Stimulator

        6.3. Market Attractiveness Analysis, by Product Type

    7. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by End-user

        7.1. Key Findings

        7.2. Market Value Forecast, by End-user

            7.2.1. Hospitals

            7.2.2. Ambulatory Surgical Centers

            7.2.3. Neurological Clinics

            7.2.4. Others

        7.3. Market Attractiveness Analysis, by End-user

    8. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Country/Region

    9. North America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Product Type, 2017–2028

            9.2.1. Single-Channel Deep Brain Stimulator

            9.2.2. Dual-Channel Deep Brain Stimulator

        9.3. Market Attractiveness Analysis, by Product Type

        9.4. Market Value Forecast, by End-user, 2017–2028

        9.5. Market Value Forecast, by End-user

            9.5.1. Hospitals

            9.5.2. Ambulatory Surgical Centers

            9.5.3. Neurological Clinics

            9.5.4. Others

        9.6. Market Attractiveness Analysis, by End-user

        9.7. Market Value Forecast, by Country/Sub-region, 2017–2028

            9.7.1. U.S.

            9.7.2. Canada

        9.8. Market Attractiveness Analysis

            9.8.1. By Product Type

            9.8.2. By End-user

            9.8.3. By Country/Sub-region

    10. Europe Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2028

            10.2.1. Single-Channel Deep Brain Stimulator

            10.2.2. Dual-Channel Deep Brain Stimulator

        10.3. Market Attractiveness Analysis, by Product Type

        10.4. Market Value Forecast, by End-user, 2017–2028

        10.5. Market Value Forecast, by End-user

            10.5.1. Hospitals

            10.5.2. Ambulatory Surgical Centers

            10.5.3. Neurological Clinics

            10.5.4. Others

        10.6. Market Attractiveness Analysis, by End-user

        10.7. Market Value Forecast, by Country/Sub-region, 2017–2028

            10.7.1. Germany

            10.7.2. U.K.

            10.7.3. France

            10.7.4. Spain

            10.7.5. Italy

            10.7.6. Rest of Europe

        10.8. Market Attractiveness Analysis

            10.8.1. By Product Type

            10.8.2. By End-user

            10.8.3. By Country/Sub-region

    11. Asia Pacific Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2028

            11.2.1. Single-Channel Deep Brain Stimulator

            11.2.2. Dual-Channel Deep Brain Stimulator

        11.3. Market Attractiveness Analysis, by Product Type

        11.4. Market Value Forecast, by End-user, 2017–2028

        11.5. Market Value Forecast, by End-user

            11.5.1. Hospitals

            11.5.2. Ambulatory Surgical Centers

            11.5.3. Neurological Clinics

            11.5.4. Others

        11.6. Market Attractiveness Analysis, by End-user

        11.7. Market Value Forecast, by Country/Sub-region, 2017–2028

            11.7.1. China

            11.7.2. Japan

            11.7.3. India

            11.7.4. Australia & New Zealand

            11.7.5. Rest of Asia Pacific

        11.8. Market Attractiveness Analysis

            11.8.1. By Product

            11.8.2. By Application

            11.8.3. By Country/Sub-region

    12. Latin America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2028

            12.2.1. Single-Channel Deep Brain Stimulator

            12.2.2. Dual-Channel Deep Brain Stimulator

        12.3. Market Attractiveness Analysis, by Product Type

        12.4. Market Value Forecast, by End-user, 2017–2028

        12.5. Market Value Forecast, by End-user

            12.5.1. Hospitals

            12.5.2. Ambulatory Surgical Centers

            12.5.3. Neurological Clinics

            12.5.4. Others

        12.6. Market Attractiveness Analysis, by End-user

        12.7. Market Value Forecast, by Country/Sub-region, 2017–2028

            12.7.1. Brazil

            12.7.2. Mexico

            12.7.3. Rest of Latin America

        12.8. Market Attractiveness Analysis

            12.8.1. By Product

            12.8.2. By Application

            12.8.3. By Country/Sub-region

    13. Middle East & Africa Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2028

            13.2.1. Single-Channel Deep Brain Stimulator

            13.2.2. Dual-Channel Deep Brain Stimulator

        13.3. Market Attractiveness Analysis, by Product Type

        13.4. Market Value Forecast, by End-user, 2017–2028

        13.5. Market Value Forecast, by End-user

            13.5.1. Hospitals

            13.5.2. Ambulatory Surgical Centers

            13.5.3. Neurological Clinics

            13.5.4. Others

        13.6. Market Attractiveness Analysis, by End-user

        13.7. Market Value Forecast, by Country/Sub-region, 2017–2028

            13.7.1. GCC Countries

            13.7.2. South Africa

            13.7.3. Rest of Middle East & Africa

        13.8. Market Attractiveness Analysis

            13.8.1. By Product

            13.8.2. By Application

            13.8.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by tier and size of companies)

        14.2. Market Share Analysis, by Company, 2020

        14.3. Company Profiles

            14.3.1. Aleva Neurotherapeutics SA

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. Financial Overview

                14.3.1.4. Strategic Overview

                14.3.1.5. SWOT Analysis

            14.3.2. Boston Scientific Corporation

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. Financial Overview

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

            14.3.3. Medtronic, Inc.

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Product Portfolio

                14.3.3.3. Financial Overview

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Medtronic

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. Financial Overview

                14.3.4.4. SWOT Analysis

                14.3.4.5. Strategic Overview

    List of Tables

    TABLE 1: Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

    TABLE 2: Relationship Between Age and the Occurrence of Parkinson’s Disease

    TABLE 3: Deep Brain Stimulation Device’s U.S. FDA approval for Various Neurological Disorders

    TABLE 4: Global Prevalence of Parkinson’s Disease, by Geography, 2017–2028 (Number of Patients)

    TABLE 5: Global Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Geography, 2017–2028

    TABLE 6: Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Region, 2017–2028

    TABLE 7: North America Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

    TABLE 8: North America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

    TABLE 9: North America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

    TABLE 10: Europe Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

    TABLE 11: Europe Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

    TABLE 12: Europe Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

    TABLE 13: Asia Pacific Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

    TABLE 14: Asia Pacific Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

    TABLE 15: Asia Pacific Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

    TABLE 16: Latin America Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

    TABLE 17: Latin America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

    TABLE 18: Latin America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

    TABLE 19: Middle East & Africa Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

    TABLE 20: Middle East & Africa Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

    TABLE 21: Middle East & Africa Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

    List of Figures

    Figure 1: Deep Brain Stimulation Devices for Parkinson’s Disease: Market Segmentation

    Figure 2: Global DBS Devices Market for Parkinson’s Disease (US$ Mn), by Region, 2020

    Figure 3: Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease (Value %), by Geography, 2020 & 2028

    Figure 4: Porter’s Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

    Figure 5: Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

    Figure 6: Market Share by Key Players: Global Deep Brain Stimulation Devices Market for Parkinson’s disease, 2020 (Value %) , by Geography, 2020

    Figure 7: United States Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017–2028

    Figure 8: Canada Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017–2028

    Figure 9: Germany Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017–2028

    Figure 10: Italy Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 11: Spain Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 12: United Kingdom Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 13: France Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 14: RoE Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 15: Australia Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 16: China Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 17: India Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 18: New Zealand Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 19: Japan Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 20: Rest of APAC Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 21: Brazil Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 22: Mexico Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 23: Latin America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

    Figure 24: Middle East & Africa Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Copyright © Transparency Market Research, Inc. All Rights reserved